SEC Form 4 · accession 0001127602-19-009283
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa Bisaccia
Officer — EVP and Chief HR Officer
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 5:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2019 | A | 6,952 | $57.83 | A | 28,038 | D | |
| Common StockF2 | Feb 28, 2019 | F | 3,015 | $57.83 | D | 25,023 | D | |
| Common Stock (restricted) | holding | — | — | — | 17,430 | D | ||
| ESOP Common Stock | holding | — | — | — | 601 | I | Direct |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
- F2Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.